New technology discovery holds promise for improved breast cancer treatment

February 1, 2009

In a study published by Nature Biotechnology online on February 1, 2009, Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumours to determine a patient's best treatment options. The tool can predict with more than 80 per cent accuracy a patient's chance of recovering from breast cancer.

"Breast cancer is the most common cancer in Canadian women," said Dr. Jeff Wrana, Senior Investigator and the Mary Janigan Research Chair in Molecular Cancer Therapeutics at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, and an International Scholar of the Howard Hughes Medical Institute. "Our hope with this technology is to eventually provide individualized analysis to breast cancer patients and their oncologists so that they are better informed and empowered to select a treatment best suited to them."

The technology, called 'DyNeMo' analyzes networks of proteins in cancer cells. Analysis of more than 350 patients found that those who survive breast cancer have a different organization of the network of proteins within the tumour cells, compared with patients who succumbed to the illness. DyNeMo can be used to predict the outcome in a newly diagnosed breast cancer patient and then assist clinicians and patients in making informed decisions on treatment. The study was led by the Mount Sinai Hospital team and co-authored by researchers at the University of Toronto and London, England's The Institute for Cancer Research.

In the future, this tool may be used to analyze other types of cancer and could be used to predict an individual's response to particular drugs.

"This research brings us one step closer to delivering individualized medicine in which healthcare professionals will be able to provide more accurate and personalized diagnoses and treatments," said Dr. Jim Woodgett, Director of Research for the Samuel Lunenfeld Research Institute of Mount Sinai Hospital.

The research was funded by Genome Canada with funds from Ontario Genomics Institute, and the Canadian Breast Cancer Foundation (CBCF) - Ontario Region. The CBCF's Interim CEO Beth Easton said the Foundation, "is pleased to play a role, along with others, in supporting the basic science behind this exciting development for breast cancer patients."

To bring this technology to patients, Mount Sinai Hospital is working to partner with the biotechnology industry, and estimates that the tool will be available to healthcare providers within the next five years.

Source: Samuel Lunenfeld Research Institute

Explore further: New ultrasound sensors for improved breast cancer screening

Related Stories

New ultrasound sensors for improved breast cancer screening

July 29, 2015

The first prototype ultrasound sensors for a new improved breast screening technique have been developed as part of a collaboration between the National Physical Laboratory (NPL), University Hospitals Bristol (UHB), North ...

How cancer cells avoid shutdown

July 6, 2015

A mechanism beyond the level of gene regulation, which is often the underlying reason for changes in protein levels, does enable the strong accumulation of a tumour promoting protease in stressed cancer cells. The group of ...

Recommended for you

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...

Quantum Theory May Explain Wishful Thinking

April 14, 2009

(PhysOrg.com) -- Humans don’t always make the most rational decisions. As studies have shown, even when logic and reasoning point in one direction, sometimes we chose the opposite route, motivated by personal bias or simply ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

thematrix606
not rated yet Feb 02, 2009
Good job, keep the strong work going!
E_L_Earnhardt
not rated yet Feb 02, 2009
Biochemicals seldom if EVER cure a cancer! I put my trust in the SURGEON! CRYOBLATION, where feasable, ALWAYS works, and a "Modified Cyroablation" is the wave of the future! A modified "Accupuncture Program"
(with cold needles) shows promise! X-ray? Not ME!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.